NST Doses First Patient in Phase 2b Clinical Study of Icosabutate in NASH ('ICONA') - b3c newswire Get link Facebook X Pinterest Email Other Apps September 27, 2019 NST Doses First Patient in Phase 2b Clinical Study of Icosabutate in NASH ('ICONA') b3c newswire Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment